Windlas Biotech P/E Ratio

WINDLAS • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
22.7
Moderate Valuation
High - Growth expectations or overvalued

Current Valuation Metrics

P/E Ratio 22.7
Current Price ₹764.50
EPS (TTM) ₹29.19
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 19.81
Historical Range 9.73 - 32.83
Percentile 60.0%

Sector Context

Sector Average 47.17
Sector Median 25.78
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹31.80
Sept 2025 ₹8.48
Mar 2025 ₹7.77

Key P/E Ratio Insights for Windlas Biotech

  • Trading at discount to sector average PE of 47.17

P/E Ratio Historical Trend for Windlas Biotech

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 32.83 31.8 ₹1044.00 NSE High
2024 16.11 29.58 ₹476.50 NSE Moderate
2023 9.73 25.17 ₹244.80 NSE Low
2022 12.91 21.29 ₹274.95 NSE Low
2021 27.45 14.83 ₹407.15 NSE High

Sector P/E Ratio Comparison

Comparing Windlas Biotech with other companies in Healthcare sector
Sector Average
47.17
Sector Median
25.78
Lowest P/E
0.9
Highest P/E
898.7
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.9 ₹31 Low
Murae Organisor MURAE 2.86 ₹41 Low
Ind Swift Laboratories INDSWFTLAB 4.48 ₹1,128 Low
Amwill Health Care AMWILL 5.98 ₹61 Low
Medicamen Organics MEDIORG 6.37 ₹25 Low
Brooks Laboratories BROOKS 6.41 ₹127 Low
Unichem Laboratories UNICHEMLAB 7.15 ₹2,100 Low
Zenith Drugs ZENITHDRUG 7.28 ₹65 Low
Galaxy Medicare GML 7.77 ₹26 Low
Vasundhara Rasayans VRL 9.19 ₹34 Low